Tousignant Jennifer

SEC Form 4 insider
Chief Legal Officer · Viridian Therapeutics, Inc.\DE ($VRDN)
1 thesis · first seen Aug 21, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-0.9%-0.9%
3d111100%-0.9%-0.9%
1w111100%-2.5%-2.5%
1m111100%-10.2%-10.2%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$VRDNSEC Form 4bearish
Sold 14,212 @ $24.50 avg · $348,194 · 2026-08-19

Form 4: Tousignant Jennifer sold VRDN

Tousignant Jennifer (Chief Legal Officer at Viridian Therapeutics, Inc.\DE) reported an open-market sale of 14,212 shares of VRDN at an average $24.50, roughly $348,194, in a Form 4 filed 2026-08-20.

At post $24.50Now $22.35-8.8% since postedas of Oct 23, 2:46 PM ET
1d-0.9%
3d-0.9%
1w-2.5%
1m-10.2%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.